Efficacious Iron for Iron Deficiency Anemia in Adults Aged ≥18 Years (NCT06303531) | Clinical Trial Compass
UnknownNot Applicable
Efficacious Iron for Iron Deficiency Anemia in Adults Aged ≥18 Years
Canada111 participantsStarted 2024-02-24
Plain-language summary
Iron deficiency anemia (IDA) is a widespread condition affecting many people globally. Despite the many cases of IDA, there are few studies that compare the effectiveness of different types of iron supplements with a greater emphasis on the cost of supplements and their tolerability. This study aims to conduct a comparison between different iron supplements to determine the superiority of the iron supplements Ferrous Ascorbate (EBMfer) and Ferrous Fumarate (Eurofer) over polysaccharide iron (FeraMax). This comparison will be conducted by determining the change in hemoglobin levels for participants in this trial over a 3-month period.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Participants must be ≥18 years of age when signing the informed consent.
✓. Participants with iron deficiency anemia are defined as follows for the purpose of this study:
Exclusion criteria
✕. Hemoglobin (Hb) ≤ 80 g/L
✕. Medical history of current hematological disorders other than iron deficiency anemia (e.g., aplastic anemia, megaloblastic anemia, sideroblastic anemia, pernicious anemia, thalassemia trait, thalassemia, sickle cell anemia, etc.).
✕. Medical history of chronic renal disease, current history of any known inflammatory disorder, and any chronic medical condition that, in the opinion of the Principal Investigator, would compromise participant safety.
✕. Medical history or evidence of intestinal malabsorption, malabsorption syndrome, hemochromatosis, and hemosiderosis, hypochlorhydria, achlorhydria, gastrectomy, and gastrojejunostomy.
✕. History of occult blood in the stool.
✕. Obvious internal or external bleeding as documented by medical history if considered clinically significant in the investigator's opinion.
What they're measuring
1
Change in Hemoglobin Levels
Timeframe: 12 Weeks from Baseline
Trial details
NCT IDNCT06303531
SponsorDr. Anil K. Gupta Medicine Professional Corporation